Home Forschung AG Experimentelle ...
Über uns
Minimalinvasive Tumortherapie
Aktuelle Stellenausschreibungen
Publikationen 20.07.2018 

Publikationen von 2000 - 2015

Direct coupling of annexin A5 to VSOP yields small, protein-covered nanoprobes for MR imaging of apoptosis.
Figge L, Appler F, Chen HH, Sosnovik DE, Schnorr J, Seitz O, Taupitz M, Hamm B, Schellenberger E.
Contrast Media Mol Imaging. 2014 Jul-Aug;9(4):291-9. doi: 10.1002/cmmi.1575.

XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation.
Haeckel A, Appler F, Figge L, Kratz H, Lukas M, Michel R, Schnorr J, Zille M, Hamm B, Schellenberger E.
J Nucl Med. 2014 Mar;55(3):508-14. doi: 10.2967/jnumed.113.128108. Epub 2014 Feb 18.

Synthetic routes to magnetic nanoparticles for MPI.
Kratz H, Eberbeck D, Wagner S, Taupitz M, Schnorr J.
Biomed Tech (Berl). 2013 Aug 15:1-7. doi: 10.1515/bmt-2012-0057. [Epub ahead of print]

Gadolinium-containing magnetic resonance contrast media: investigation on the possible transchelation of GdXXX to the glycosaminoglycan heparin.
Taupitz M, Stolzenburg N, Ebert M, Schnorr J, Hauptmann R, Kratz H, Hamm B, Wagner S.
Contrast Media Mol Imaging. 2013 Mar-Apr;8(2):108-16. doi: 10.1002/cmmi.1500.

Imaging of magnetic microfield distortions allows sensitive single-cell detection.
Lindquist RL, Papazoglou S, Scharlach C, Waiczies H, Schnorr J, Taupitz M, Hamm B, Schellenberger E.
Mol Imaging. 2013 Mar-Apr;12(2):83-9.

Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization.
Wagner S, Schnorr J, Ludwig A, Stangl V, Ebert M, Hamm B, Taupitz M.
Int J Nanomedicine. 2013;8:767-79. doi: 10.2147/IJN.S38702. Epub 2013 Feb 20.

Inhibition of neointimal proliferation after bare metal stent implantation with low-pressure drug delivery using a paclitaxel-coated balloon in porcine coronary arteries.
Cremers B, Kelsch B, Clever YP, Hattangadi N, Mahnkopf D, Speck U, Taupitz M, Scheller B.
Clin Res Cardiol. 2012 Jan 12. [Epub ahead of print]

Cardiac Magnetic Resonance Angiography using Blood-Pool Contrast Agents: Comparison of Citrate-Coated Very Small Superparamagnetic Iron Oxide Particles with Gadofosveset Trisodium in Pigs.
Schnorr J, Taupitz M, Schellenberger EA, Warmuth C, Fahlenkamp UL, Wagner S, Kaufels N, Wagner M.
Rofo. 2012 Feb;184(2):105-112. Epub 2011 Dec 16.

Combined in situ zymography, immunofluorescence, and staining of iron oxide particles in paraffin-embedded, zinc-fixed tissue sections.
Haeckel A, Schoenzart L, Appler F, Schnorr J, Taupitz M, Hamm B, Schellenberger E.
Mol Imaging. 2012 Sep-Oct;11(5):383-8.

Straightforward thiol-mediated protein labelling with DTPA: Synthesis of a highly active 111In-annexin A5-DTPA tracer.
Kratz H, Haeckel A, Michel R, Schönzart L, Hanisch U, Hamm B, Schellenberger E.
EJNMMI Res. 2012 Apr 27;2(1):17. doi: 10.1186/2191-219X-2-17.

Electrostatically Stabilized Magnetic Nanoparticles - An Optimized Protocol to Label Murine T Cells for in vivo MRI
Wuerfel E, Smyth M, Millward JM, Schellenberger E, Glumm J, Prozorovski T, Aktas O, Schulze-Topphoff U, Schnorr J, Wagner S, Taupitz M, Infante-Duarte C, Wuerfel J.
Front Neurol. 2011;2:72. Epub 2011 Dec 16

Combined In Situ Zymography, Immunofluorescence, And Staining Of Iron Oxide Particles In Paraffin-embedded, Zinc-fixed Tissue Sections.
Haeckel A, Schoenzart L, Appler F, Schnorr J, Taupitz M, Hamm B., Schellenberger E.
Mol Imaging. 2011;11(5):1-6.

Bioresponsive nanosensors in medical imaging.
Schellenberger E.
J R Soc Interface. 2010 Feb 6;7 Suppl 1:S83-91. Epub 2009 Oct 21.

Effects of water exchange on MRI-based determination of relative blood volume using an inversion-prepared gradient echo sequence and a blood pool contrast medium.
Carreira GC, Gemeinhardt O, Beyersdorff D, Schnorr J, Taupitz M, Lüdemann L.
Magn Reson Imaging. 2009 Apr;27(3):360-9. Epub 2008 Sep 2.

Protease-specific nanosensors for magnetic resonance imaging.
Schellenberger E, Rudloff F, Warmuth C, Taupitz M, Hamm B, Schnorr J. 
Bioconjug Chem. 2008 Dec;19(12):2440-5

Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial.
Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U, Ricke J.
Circulation. 2008 Sep 23;118(13):1358-65. Epub 2008 Sep 8.

Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases.
Kaufels N, Korn R, Wagner S, Schink T, Hamm B, Taupitz M, Schnorr J.
Invest Radiol. 2008 Jul;43(7):496-503.

Linking proteins with anionic nanoparticles via protamine: ultrasmall protein-coupled probes for magnetic resonance imaging of apoptosis.
Schellenberger E, Schnorr J, Reutelingsperger C, Ungethüm L, Meyer W, Taupitz M, Hamm B.
Small. 2008 Feb;4(2):225-30.

Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries.
Speck U, Scheller B, Abramjuk C, Breitwieser C, Dobberstein J, Boehm M, Hamm B. 
Radiology. 2006 Aug;240(2):411-8.

Focal Liver Lesions: SPIO-, Gadolinium-, and Ferucarbotran-enhanced Dynamic T1-weighted and Delayed T2-weighted MR Imaging in Rabbits.
Schnorr J, Wagner S, Abramjuk C, Drees R, Schink T, Schellenberger EA, Pilgrimm H, Hamm B, Taupitz M.
Radiology. 2006 Jul;240(1):90-100. Epub 2006 May 9.

Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in rats.
Abramjuk C., Jung K., Krell H.W., Juchem R., Peters R., Taymoorian K., Staack A., Stephan C., Schnorr J., Loening S.A. & Lein M.
Anti-Cancer Drug: 16(8) 855-61, Jahr: "2005"

Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
Gemeinhardt O., Lüdemann L., Prochnow D., Abramjuk C., Taupitz M., Hamm B. & Beyersdorff D.
Rofo-Fortschr Rontg: 177(7) 935-9, Jahr: "2005"

Implementation of a rapid inversion-prepared dual-contrast gradient echo sequence for quantitative dynamic contrast-enhanced magnetic resonance imaging of the human prostate.
Prochnow D., Beyersdorff D., Warmuth C., Taupitz M., Gemeinhardt O. & Lüdemann L.
Magn Reson Imaging: 23(10) 983-90, Jahr: "2005"

[Applications of optical imaging]
Schellenberger E.
Z Med Phys: 15(3) 187-91, Jahr: "2005"

Drug delivery by angiographic contrast media: inhibition of restenosis.
Speck U., Scheller B., Abramjuk C. & Bernhardt U.
Acad Radiol: 12 Suppl 1 S14-7, Jahr: "2005"

Surface-functionalized nanoparticle library yields probes for apoptotic cells.
Schellenberger E.A., Reynolds F., Weissleder R. & Josephson L.
Chembiochem: 5(3) 275-9, Jahr: "2004"

Optimal modification of annexin V with fluorescent dyes.
Schellenberger E.A., Weissleder R. & Josephson L.
Chembiochem: 5(3) 271-4, Jahr: "2004"

Comparison of the iron oxide-based blood-pool contrast medium VSOP-C184 with gadopentetate dimeglumine for first-pass magnetic resonance angiography of the aorta and renal arteries in pigs.
Schnorr J., Wagner S., Abramjuk C., Wojner I., Schink T., Kroencke T.J., Schellenberger E., Hamm B., Pilgrimm H. & Taupitz M.
Invest Radiol: 39(9) 546-53, Jahr: "2004"

Inhibition of restenosis in stented porcine coronary arteries: uptake of Paclitaxel from angiographic contrast media.
Speck U., Scheller B., Abramjuk C., Grossmann S., Mahnkopf D. & Simon O.
Invest Radiol: 39(3) 182-6, Jahr: "2004"

Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging.
Taupitz M., Wagner S., Schnorr J., Kravec I., Pilgrimm H., Bergmann-Fritsch H. & Hamm B.
Invest Radiol: 39(7) 394-405, Jahr: "2004"

[MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs]
Schnorr J., Wagner S., Ebert W., Heyer C., Laub G., Kivelitz D., Abramjuk C., Hamm B. & Taupitz M.
Rofo-Fortschr Rontg: 175(6) 822-9., Jahr: "2003"

Dr. med. vet. Jörg Schnorr

 Dr. Bohner - kommissarische Leitung Neuroradiologie
seit 01.04. neuer kommissarischer Leiter Neuroradiologie
 Matrix in Vision
Die DFG fördert einen umfangreichen Sonder-forschungsbereich zum Thema extrazelluläre Matrix. Sprecher ist Prof. Dr. B. Hamm. Mehr lesen....
 Projektförderung Experimentelle Neuroradiologie
Projektförderung für das Team von Dr. med. Omar Dzaye Ph.D.
Goldmedaille der AOSR an Prof. Hamm verliehen
 Graduiertenkollegs BIOQIC der DFG
Wir freuen uns über die Einrichtung des Graduiertenkollegs BIOQIC der DFG (GRK2260) an der Radiologie der Charité!
 PD Dr. Fallenberg - DEGUM Stufe III
Nachdem Frau PD Dr. Eva Maria Fallenberg aus der Klinik für Radiologie der Charité auf dem diesjährigen Deutschen Röntgenkongress zur Vorsitzenden der ...
alle Nachrichten
Home   Site Map   Impressum   Kontakt   Top    Copyright © 2003-2010 Charité
entwickelt und betreut von Martin Fischer